Insights

Loading spinner
Gathering insights about MindImmune Therapeutics

MindImmune Therapeutics Tech Stack

MindImmune Therapeutics uses 8 technology products and services including Twemoji, Priority Hints, PHP, and more. Explore MindImmune Therapeutics's tech stack below.

  • Twemoji
    Font Scripts
  • Priority Hints
    Performance
  • PHP
    Programming Languages
  • HSTS
    Security
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management
  • HTTP/3
    Web & Portal Technology
  • MonsterInsights
    Web Platform Extensions

Media & News

MindImmune Therapeutics's Email Address Formats

MindImmune Therapeutics uses at least 1 format(s):
MindImmune Therapeutics Email FormatsExamplePercentage
LastF@mindimmune.comDoeJ@mindimmune.com
100%

Frequently Asked Questions

Where is MindImmune Therapeutics's headquarters located?

Minus sign iconPlus sign icon
MindImmune Therapeutics's main headquarters is located at Providence, Rhode Island United States. The company has employees across 1 continents, including North America.

What is MindImmune Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
MindImmune Therapeutics's official website is mindimmune.com and has social profiles on LinkedInCrunchbase.

What is MindImmune Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
MindImmune Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MindImmune Therapeutics have currently?

Minus sign iconPlus sign icon
As of April 2026, MindImmune Therapeutics has approximately 14 employees across 1 continents, including North America. Key team members include Chief Executive Officer: I. S.Chief Scientific Officer: L. G.Co-Founder | Vice President Of Biology: B. N.. Explore MindImmune Therapeutics's employee directory with LeadIQ.

What industry does MindImmune Therapeutics belong to?

Minus sign iconPlus sign icon
MindImmune Therapeutics operates in the Biotechnology Research industry.

What technology does MindImmune Therapeutics use?

Minus sign iconPlus sign icon
MindImmune Therapeutics's tech stack includes TwemojiPriority HintsPHPHSTSX-XSS-ProtectionGoogle Tag ManagerHTTP/3MonsterInsights.

What is MindImmune Therapeutics's email format?

Minus sign iconPlus sign icon
MindImmune Therapeutics's email format typically follows the pattern of LastF@mindimmune.com. Find more MindImmune Therapeutics email formats with LeadIQ.

How much funding has MindImmune Therapeutics raised to date?

Minus sign iconPlus sign icon
As of April 2026, MindImmune Therapeutics has raised $750K in funding. .

When was MindImmune Therapeutics founded?

Minus sign iconPlus sign icon
MindImmune Therapeutics was founded in 2016.

MindImmune Therapeutics

Biotechnology ResearchRhode Island, United States11-50 Employees

MindImmune is a biopharmaceutical company targeting the inflammatory drivers of Alzheimer's Disease and other neurodegenerative disorders. MindImmune scientists are at the forefront in recognizing the therapeutic opportunities in modulating the immune system to treat brain disease.

Section iconCompany Overview

Headquarters
Providence, Rhode Island United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $750K

    MindImmune Therapeutics has raised a total of $750K of funding over 2 rounds. .

  • $10M$25M

    MindImmune Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $750K

    MindImmune Therapeutics has raised a total of $750K of funding over 2 rounds. .

  • $10M$25M

    MindImmune Therapeutics's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.